Suspension of trading
Valuation Exscientia plc
Stocks
EXAI
US30223G1022
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/11/24 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/11/24 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Company Valuation: Exscientia plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 1,757 | 543.6 | 628.7 |
| Change | - | -69.06% | 15.67% |
| Enterprise Value (EV) 1 | 1,200 | 51.65 | 284.6 |
| Change | - | -95.69% | 451% |
| P/E | -14.8x | -4.55x | -4.28x |
| PBR | 3.11x | 1.14x | 1.78x |
| PEG | -0x | 3.03x | -0.2x |
| Capitalization / Revenue | 64.2x | 20x | 31.3x |
| EV / Revenue | 43.9x | 1.9x | 14.2x |
| EV / EBITDA | -23.4x | -0.32x | -1.75x |
| EV / EBIT | -22x | -0.31x | -1.63x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.9871 | -0.9722 | -1.175 |
| Distribution rate | - | - | - |
| Net sales 1 | 27.36 | 27.22 | 20.08 |
| EBITDA 1 | -51.31 | -159.9 | -162.5 |
| EBIT 1 | -54.64 | -167.6 | -174.5 |
| Net income 1 | -49.23 | -118.7 | -146 |
| Net Debt 1 | -557 | -491.9 | -344.1 |
| Reference price 2 | 14.593 | 4.424 | 5.032 |
| Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 |
| Announcement Date | 23/03/22 | 23/03/23 | 21/03/24 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 633M | ||
| 35.1x | 6.14x | 18.98x | 0.94% | 50.35B | ||
| -23.1x | 337.19x | -21.24x | -.--% | 39.21B | ||
| 25.17x | 2.79x | 12.05x | -.--% | 34.52B | ||
| 46.88x | 4.72x | 30.24x | -.--% | 34.6B | ||
| 27.13x | 7.96x | 19.97x | 0.42% | 27.05B | ||
| 31.25x | 5.03x | 22.91x | -.--% | 15.11B | ||
| 24.07x | 2.05x | 9x | 1.11% | 13.85B | ||
| 24.32x | 1.93x | 11.7x | -.--% | 13.18B | ||
| Average | 23.85x | 45.98x | 12.95x | 0.31% | 25.39B | |
| Weighted average by Cap. | 22.88x | 62.03x | 12.07x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EXAI Stock
- Valuation Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
















